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ABSTRACT
Osteoarthritis is a degenerative joint disease that is characterized by subchondral bone changes. These changes may be associated
with bone remodelling, which involve coordinative functions between bone formation and resorption markers such as
osteoprotegerin (OPG) and receptor activator of nuclear factor kB ligand (RANKL), respectively. Previous studies have
shown that the structural changes were different between the subchondral bone plate and trabecular bone. However, the
expression of bone formation and bone resorption markers underlying the differences between these two regions has yet to
be determined. Hence, the present study aims to determine the structural changes and expressions of OPG/RANKL in the
subchondral bone plate and trabecular bone during the development of osteoarthritis in Dunkin Hartley guinea pigs. Eighteen
tibias were scanned using a micro-computed tomography at three different time points; 10, 20 and 30 weeks of age to determine
their subchondral bone plate and trabecular bone thickness. Immunohistochemistry and histopathology methods were conducted
to determine the expression of OPG/RANKL and microscopic osteoarthritis score, respectively. The results showed that
subchondral bone plate and trabecular bone thickness were greater in the medial than the lateral side of the tibial plateau, and
increased significantly with ageing (p < 0.01). In addition, across the time points, the OPG/RANKL ratio of medial Sbp
initially increased, before decreasing at the final time point. In contrast, the OPG/RANKL ratio of medial Tb was initially
constant but then decreased at 30 weeks of age. Interestingly, a significant correlation was observed between the subchondral
bone plate thickness and OPG/RANKL ratio with microscopic osteoarthritis scores (r = 0.5, p < 0.05), suggesting that the
subchondral bone plate plays an important role in the pathogenesis of osteoarthritis.
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INTRODUCTION
Osteoarthritis (OA) is the most common form of
deteriorative joint disease that leads to pain and
walking disability (Zhang & Jordan, 2010). It is
characterized by the thinning of the articular
cartilage (Zamli et al., 2014), thickening of
subchondral bone plate and structural changes of
trabecular bone (Bobinac et al., 2013). These
changes may occur as a result of the joint tissue
remodelling (Sharma et al., 2013). The bone
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remodelling is a process of two main sequential
events; bone resorption and followed by bone
formation. Bone resorption begins when osteoclasts
break down the old bone. Meanwhile, the bone
formation is rebuilding a new bone tissue by the
osteoblasts (Logar et al., 2007). A continuous bone
remodelling is necessary to maintain the structural,
metabolic and biomechanics properties of the
bone (Zamli et al., 2014). However, abnormal
bone remodelling may lead to diseases such as
osteoporosis (Lawrence, 2005) and OA (Huebner &
Kraus, 2006).
Osteoprotegerin (OPG) and receptor activator of
nuclear factor kb ligand (RANKL) are examples of
biomarkers that can be used to determine the state
of bone formation and bone resorption, respectively
(Boyce & Xing, 2008). Both OPG and RANKL are
expressed by osteoblasts, osteocytes and stromal
cells (Fujiwara et al., 2016). RANKL is essential for
starting bone resorption through the enhancement
of osteoclast differentiation and proliferation after
binding to RANK. On the other hand, OPG plays
an important role to protect the bone from being
excessively resorpted by binding to RANKL, and as
a consequence, it prevents RANKL from binding to
RANK (Logar et al., 2007). OPG/RANKL ratio is
commonly used as an indicator of bone remodelling
activities, in which a high ratio level of OPG/
RANKL is an indicative of promoting bone
formation while a low level ratio of OPG/RANKL
favours bone resorption (Kwan Tat & Pelletier,
2008).
Previous studies have shown that the structural
changes such as subchondral bone thickness were
different between subchondral bone plate and
trabecular bone (Mastbergen & Lafeber, 2011; Burr
& Gallant, 2012). However, the expression of OPG
and RANKL markers that underlie the differences
between these two regions has yet to be determined.
Hence, the present study aims to determine the
structural changes and expressions of OPG/RANKL
in subchondral bone plate and trabecular bone
during the development of spontaneous OA in knee
joints of Dunkin Hartley guinea pigs. It is expected
that the structural changes and biochemical markers
of bone remodelling are higher in the medial side
of subchondral bone plate than the other side/region
during the early development of OA in the Dunkin
Hartley guinea pigs. If this hypothesis is proven to
be true, the search for potential OA treatment
involving bones needs to be targeting the specific




Eighteen male Dunkin Hartley guinea pigs were
purchased from the Laboratory Animal Research
Unit, Faculty of Medicine, Universiti Kebangsaan
Malaysia at seven weeks of age and around 250 g
of average weight. They were kept at the Animal
House, Kulliyyah of Pharmacy, International
Islamic University Malaysia (IIUM) before being
euthanised at ten, 20 and 30 weeks of age by an
administration of 1 mL/kg of pentobarbitone sodium
via intramuscular injection. The knee joint was
dissected and the soft tissues were removed. Then,
the tibia was fixed in 10% of neutral buffered
formalin (Merck, USA) solution and kept at room
temperature for further analysis. These protocols
were approved by the Institutional Animal Care and
Use Committee (IACUC), IIUM (IIUM/IACUC
Approval/ (10) (62)).
Micro-computed Tomography scanning and
analysis
The tibia was scanned with Micro-computed
tomography scanner (Skyscan 1176) at 180° rotation
with a resolution of 9 µm in anterior posterior
position. The voltage of the X-ray tube was set to
65 kV and the current at 153 µA with a 1.0 mm
aluminium filter. For the image reconstruction, a
modified Fieldcamp algorithm was used and
undertaken by using the NRecon software (Version
1.6.1.5, Skyscan, Kontich, Belgium). The recon-
structed images were then analysed by using Bruker
SkyScan CT-Analyser (CTAn) software (Version
1.9.2.5, SkyScan, Kontich, Belgium). GIMP 2.8.18
software was used to superimpose a standard grid on
each constructed image. The subchondral bone plate
thickness was then determined by measuring the
distance between the osteochondral junction to
intersection between the subchondral bone plate and
trabecular bone.
Histological process
The fixed tibias were decalcified in Decalcifier
II (Leica Biosystem, USA) for about six hours. The
tibias were then processed in a tissue processor,
embedded in paraffin (Leica Biosystem, USA) and
cut at 2.5 µm and 4.0 µm by using a microtome for
immunohistochemistry and histopathology analysis,
respectively.
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Immunohistochemistry staining and analysis
The tissue sectioned underwent a pre-treatment
process of deparaffinisation and rehydration
according to the protocol at Lab Histopathology,
Kulliyyah of Medicine, IIUM. Next, antigen
retrieval was conducted using PT Link system
(DAKO, USA) at pH9, 97°C for 20 minutes. Then
the slides were washed using neutral buffer solution
and incubated for 2 hours with primary antibody
of rabbit polyclonal antibody OPG (1:1000) and
RANKL (1:200) (Abcam Hong Kong Ltd.), followed
by the secondary antibody (Dako REAL™
EnVision™/HRP, Rabbit/Mouse) for 30 minutes.
The DAB (DAKO, USA) was used to develop brown
colour and counterstained with haematoxylin. All
these staining procedures were done using universal
auto-stain (DAKO, USA). The sample appearing
brownish yellow was considered as positive staining.
The captured images (Olympus BX51M) were
analysed by counting the percentage of positive
stained cells over the total cells presented in the
section using Image J software.
Histopathological analysis of articular cartilage
The sectioned tissues were stained with 0.04%
toluidine blue prepared in 0.1 M sodium acetate
buffer (pH 4) for 5 minutes. The images of stained
sections were captured by using Olympus BX51M
camera and the blindly scored by using Osteo-
arthritis Research Society International (OARSI)
system (Kraus et al., 2010). The medial and lateral
side of each articular cartilage were assessed and
scored in terms of its structure, proteoglycan
content, cellularity and tidemark integrity.
Statistical analysis
The data were statistically analysed by using
the Statistical Package for the Social Sciences
(SPSS) 12.0.1 software. The data were analysed by
comparing between the medial and lateral sides and
time points at ten, 20 and 30 weeks of age by using
Paired T-test / Wilcoxon Signed Rank Test, and
Analysis of Variance (ANOVA)/ Kruskal Wallis Test,
respectively. Partial correlation was used to explore
the relationship between Sbp and Tb thickness,
OPG/RANKL ratio with AC degeneration, while
controlling for weight and age. The data were
presented as mean ± standard error of mean (SEM).
A significant difference of p < 0.05 and p < 0.01 was
denoted as * and **, respectively.
RESULTS
Micro-Computed Tomography
Figure 1 shows the subchondral bone plate in
the medial side was significantly thicker than the
lateral side of the tibia at 10 [medial: 146.67 ± 5.578
ìm, lateral: 130.83 ± 4.729 µm; p = 0.003], 20
[medial: 396.67 ± 27.467 ìm, lateral: 355.83 ±
31.369 µm; p: 0.001] and 30 weeks of age [medial:
630.83 ± 12.276 µm, lateral: 581.67 ± 14.53 µm;
p: 0.006]. The subchondral bone plate thickness
increased across the time points in both sides of the
tibia. These changes were statistically significant
(p < 0.01).
Unlike the subchondral bone plate thickness,
there was no significant difference of trabecular
bone thickness between sides at 10 [medial: 71.21
Fig. 1. Mean values of subchondral bone plate thickness in the medial and lateral side of Dunkin
Hartley guinea pigs tibia at ten, 20 and 30 weeks of age. A significant difference of p < 0.01
was denoted as **. Error bars represent Standard Error Mean (SEM).
90 OSTEOPROTEGERIN (OPG) AND RECEPTOR ACTIVATOR OF NUCLEAR FACTOR kB LIGAND (RANKL)
± 4.396 µm, lateral: 70.54 ± 3.529 µm], 20 [medial:
82.02 ± 1.796 µm, lateral: 81.41 ± 2.508 µm] and
30 weeks of age [medial: 118.16 ± 3.29 µm, lateral:
116.88 ± 2.269 µm] (Figure 2). However, these
changes were statistically significant across the time
points in both sides of the tibia (p < 0.01).
Immunohistochemistry
Figure 3 shows the representative micrographs
of medial subchondral bone plate stained with OPG
and RANKL at 10 (A and B), 20 (C and D) and 30
(E and F) weeks of age. Generally, the expression
of OPG by the osteocytes in the medial subchondral
bone plate was most pronounced at 20 weeks of age,
while positively stained osteocytes by RANKL were
predominantly observed at ten weeks of age and
decreased with ageing.
Figure 4 shows the mean of OPG/RANKL ratios
of positively-stained cells in the subchondral bone
plate was initially higher in the medial than the
lateral sides at 10 [medial: 0.92 ± 0.055, lateral: 0.88
± 0.005] and 20 [medial: 1.27 ± 0.005, lateral: 1.02
± 0.01] weeks of age. However, at 30 weeks of age
it became lower in the medial than the lateral side
[medial: 0.54 ± 0.01, lateral: 0.64 ± 0.01]. Across
the time point, the mean of OPG/RANKL ratio in
both sides of subchondral bone plate initially
increased between ten to 20 weeks of age (p > 0.05).
However, at the final time points, the OPG/RANKL
ratio decreased, and even further, in the medial side
of the subchondral bone plate (p > 0.05).
Unlike the subchondral bone plate, the
expression of both OPG and RANKL decreased as
age increased (Figure 5 A-F). The mean of OPG/
RANKL ratios of positively-stained cells in the
medial side of the trabecular bone was lower than
the lateral side at 10 [medial: 0.605 ± 0.005, lateral:
1.00 ± 0.00] and 20 [medial: 0.59 ± 0.01, lateral:
0.795 ± 0.005] weeks of age. However, the trend
changed at 30 weeks of age in which the mean of
OPG/RANKL ratio was higher in the medial side
than the lateral side [medial: 0.27 ± 0.00, lateral:
0.10 ± 0.005]. Across the time point, the mean of
OPG/RANKL ratio in both sides of the trabecular
bone slightly decreased between 10 to 20 weeks of
age, but then drastically decreased at 30 weeks of
age (p > 0.05).
Histopathology
Generally, the morphological changes of AC in
the osteoarthritic knee joint was more prominent
in the medial than the lateral side of the Dunkin
Hartley guinea pigs tibia. The fibrillation of AC
surface, loss of PG content and cellularity became
worse as the age increased (Figure 7).
Figure 8 shows the total OARSI score was about
the same for both medial and lateral side at ten
weeks of age [medial: 5.33 ± 0.667; lateral: 5.00 ±
0.577]. However, as the age increased, the medial
side shows higher score than the lateral side and
reached statistical significance at 30 weeks of age
[medial: 13.33 ± 1.53; lateral: 10.67 ± 1.53; p =
Fig. 2. Mean values of trabecular bone thickness in the medial and lateral side of Dunkin Hartley
guinea pigs tibia at ten, 20 and 30 weeks of age. A significant difference of p < 0.01 was denoted
as **. Error bars represent Standard Error Mean (SEM).
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Fig. 3. Representative micrograph of subchondral bone plate stained with OPG and RANKL at ten (A and B), 20 (C and D)
and 30 (E and F) weeks of age. The OPG/RANKL positive and negative osteocytes appear brownish (red arrow) and bluish
(white arrow), respectively. Magnification: 200×.
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Fig. 4. Mean values of OPG/RANKL ratio of positively-stained osteocytes in the subchondral
bone plate at the medial and lateral side of Dunkin Hartley guinea pigs tibia at ten, 20 and 30
weeks of age. Error bars represent Standard Error Mean (SEM).
0.015]. Across the time points, the OARSI scoring
increased with ageing and was statistically signi-
ficant between ten to 20 weeks of age (medial:
p = 0.008; lateral: p = 0.014).
Correlation between the structural and molecular
changes of subchondral bone and severity of OA
A significant correlation was observed between
the total OARSI scores and the subchondral bone
plate thickness (r = 0.524, p = 0.037) and OPG/
RANKL ratio (r = -0.669, p = 0.034).
DISCUSSION
The present study highlights a number of important
findings on the role of subchondral bone
remodelling and its association with articular
cartilage degeneration during the initiation and
progression of spontaneous OA in Dunkin Hartley
guinea pigs. The subchondral bone plate was
significantly thicker in the medial than the lateral
sides of the tibia and dramatically increased with
ageing. Unlike the trabecular bone, the OPG/
RANKL ratio of medial subchondral bone plate
initially increased, before decreasing at 30 weeks of
age. These changes progressed as a function of age
and were significantly associated with the articular
cartilage degeneration.
The data showed that the Sbp thickness was
significantly greater in the medial than the lateral
side of the tibia, which was consistent with previous
studies in human and other animal models of OA
(Goker et al., 2000; Weng et al., 2010; Zamli et al.,
2014). Although not statistically significant, the
medial side of the tibia also had more pronounced
articular cartilage degeneration as compared to the
opposite side of the tibia. As suggested by Intema
et al. (2010), the medial side of the tibia has higher
susceptibility to these structural changes due to
the varus malalignment of the knee joint. This
malalignment occurs as a result of unequal load
distribution of the body weight between the two
sides of the knee joint, resulting in higher
susceptibility towards OA in the medial side of the
tibia as it receives more stress than the opposite side
(Patel et al., 2003).
Across the time points, the initial increase of
OPG/RANKL ratio in the medial side of subchondral
bone plate was attributed to the over expression of
OPG, in respect to RANKL, that could tip the
balance of subchondral bone remodelling toward
bone formation. However, despite of continuous
increase of subchondral bone plate thickness
between 20 and 30 weeks of age, the OPG/RANKL
ratio of medial subchondral bone plate decreased
and became even lower than in the lateral side of
the tibia. The present findings appear contradictory
with those of Sniekers et al. (2012) and Bellido et
al. (2010), who reported an early subchondral bone
plate loss following a surgical induction of OA in
dog and rabbit, respectively. The discrepancy in
findings may be due to the different pathogenesis
between spontaneous and induced animal models of
OA.
 In human, however, a significant lower OPG/
RANKL ratio was observed in a patient with
advanced knee OA as compared to healthy control
subjects (Tat & Pelletier, 2008; Pilichou et al.,
2008), suggesting the subchondral bone resorption
predominates over bone formation during the late
stage of OA. Interestingly, the decrease of OPG/
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Fig. 5. Representative micrograph of trabecular bone stained with OPG and RANKL at ten (A and B), 20 (C and D) and 30
(E and F) weeks of age. The OPG/RANKL positive and negative osteocytes appear brownish (red arrow) and bluish (white
arrow), respectively. Magnification: 200×.
RANKL ratio was not limited to osteoblasts in the
osteoarthritic subchondral bone but also consistent
with the expression of OPG/RANKL in OA
chondrocytes (Kwan Tat et al., 2009), the effect of
which could be reversed by inhibiting the resorptive
signals from the chondrocytes via celecoxib
treatment (Moreno-Rubio et al., 2010).
Intriguingly, although the present study
indicates higher subchondral bone plate resorption
between 20 and 30 weeks of age, the subchondral
bone plate thickness continuously increased
significantly until the final time point. To the
knowledge of the researcher, this is the first study
that demonstrates a significant inverse association
between the subchondral bone plate thickening and
OPG/RANKL ratio in spontaneous animal model of
OA. It is hypothesised that, instead of thinning, the
subchondral bone plate becomes porous at the late
stage of OA, as a result of abnormal subchondral
bone remodelling (Wen et al., 2013; Hayami et al.,
2004; Bellido et al., 2010). Further studies in human
and animal models of OA are needed to confirm the
above hypothesis.
This study has several limitations. First, lack of
significant difference between side and time points
in some analyses could be due to limited numbers
of animal per time point. Second, the absence of
growth-match disease free control for Dunkin Hartley
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Fig. 6. Mean values of OPG/RANKL ratio of positively-stained osteocytes in the trabecular
bone at the medial and lateral side of Dunkin Hartley guinea pigs tibia at ten, 20 and 30
weeks of age. Error bars represent Standard Error Mean (SEM).
Fig. 7. Representative histological images of the medial and lateral articular cartilage of Dunkin Hartley tibia stained with
toluidine blue at ten (A and B), 20 (C and D) and 30 (E and F) weeks of age. Magnification: 200×.
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Fig. 8. Mean values of total OARSI score of articular cartilage in medial and lateral side of Dunkin
Hartley guinea pigs at ten, 20 and 30 weeks of age. A significant difference of p < 0.05 and p <
0.01 was denoted as * and ** respectively. Error bars represent Standard Error Mean (SEM).
guinea pigs may lead to the wrong interpretation of
subchondral bone changes that are due to growth
or pathology. Nevertheless, this study used the
lateral side of the tibia as the internal control
because both sides of the tibia have similar growth
rate.
CONCLUSION
Taken together, the present findings show that
the structural and OPG/RANKL changes in the
subchondral bone are more prominent in the medial
than the lateral side of the Dunkin Hartley tibia.
Unlike the trabecular bone, a significant correlation
between the subchondral bone plate thickening and
OPG/RANKL expression with articular cartilage
degeneration suggests that the subchondral bone
plate plays an important role in the pathogenesis of
OA. Thus, the search for potential OA treatment
involving bones needs to be targeting the specific
regions of subchondral bone, and also consider the
stage of disease.
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